All Times EDT
Legend: CC = Walter E. Washington Convention Center M = Marriott Marquis Washington, DC
Activity Details
53 * !
Sun, 8/7/2022,
4:00 PM -
5:50 PM
CC-143B
Considerations in Selection of the Appropriate Intercurrent Event Strategies for Estimands: Hypothetical vs. Composite vs. Treatment Policy — Topic Contributed Papers
Biopharmaceutical Section , ENAR, Biometrics Section
Organizer(s): Pilar Lim, Janssen Research & Development, LLC
Chair(s): Elena Polverejan, PhD, Janssen Research & Development, LLC
4:05 PM
Hypothetical Conversations: Which Estimand Strategies Are Clinically Relevant When Trial Participants Do Not Follow Clinically Relevant Protocol Guidelines?
Bohdana Ratitch, Bayer Inc., Canada ; Katrin Roth, Bayer
4:25 PM
Treatment Policy Estimation – Hidden Sources of Bias
Michael Paul O'Kelly, IQVIA ; Sylvia Siying Li, IQVIA
4:45 PM
Targeting Composite Estimands Using Trimmed Means
Alex Ocampo, Novartis Pharma AG
5:05 PM
Discussant: Hsien-Ming 'James' Hung, PhD, U. S. FDA
5:25 PM
Discussant: Yongming Qu, PhD, Lilly
5:45 PM
Floor Discussion
Video Available to all JSM Registered Attendees. Please
login to view .
